CERO Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- CERO Therapeutics's estimated annual revenue is currently $1.7M per year.
- CERO Therapeutics's estimated revenue per employee is $106,563
Employee Data
- CERO Therapeutics has 16 Employees.
- CERO Therapeutics grew their employee count by 23% last year.
CERO Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CFO | Reveal Email/Phone |
2 | Chief Financial Officer | Reveal Email/Phone |
3 | Sr. Director | Reveal Email/Phone |
4 | Principal Scientist | Reveal Email/Phone |
5 | Scientist | Reveal Email/Phone |
6 | Assistant Professor, UCSF Division Hematology/Oncology; Hematologist, Zuckerberg SF General Hosp | Reveal Email/Phone |
7 | Principal Scientist - Viral Vector | Reveal Email/Phone |
8 | Senior Research Associate | Reveal Email/Phone |
9 | Senior Research Associate | Reveal Email/Phone |
CERO Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 5 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 4 | -50% | N/A | N/A |
#6 | $0.7M | 8 | 0% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 17 | 31% | N/A | N/A |
What Is CERO Therapeutics?
At CERo, we are expanding the armamentarium of engineered cell therapies to create a whole new class of innovative medicines for oncology. Armed with an understanding of cellular clearance and molecular immunology, we engineer cells to engage new and complementary cell elimination pathways to enable deeper and more sustained clinical responses to maximize wellness.
keywords:N/A
N/A
Total Funding
16
Number of Employees
$1.7M
Revenue (est)
23%
Employee Growth %
N/A
Valuation
N/A
Accelerator
CERO Therapeutics News
2022-04-17 - MarketsandMarkets Biopharma Series - Healthcare Trends, Innovations & Disruptions Under One Roof!
Immune Checkpoint Inhibitors and Combination Therapies. ... Senior Vice President, Head, Translational Medicine, CERo Therapeutics
Other Companies in South San Francisco
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.4M | 17 | -6% | N/A |
#2 | $0M | 18 | -14% | $301.3M |
#3 | $2.8M | 18 | -53% | N/A |
#4 | $188M | 18 | -44% | $127.8M |
#5 | $2.8M | 18 | -18% | N/A |